12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. Agape ATP (ATPC) saw a 39.2% increase, CNS Pharma (CNSP) rose by 14.52%, and Ekso Bionics Holdings (EKSO) went up by 10.22%. Oncternal Therapeutics (ONCT) and NanoVibronix (NAOV) also saw gains of 9.56% and 8.21%, respectively. Alaunos Therapeutics (TCRT) increased by 7.79%. Conversely, OneMedNet (ONMD) dropped by 12.6%, Palisade Bio (PALI) by 10.95%, Adaptimmune Therapeutics (ADAP) by 6.77%, Butterfly Network (BFLY) by 6.53%, Soleno Therapeutics (SLNO) by 6.11%, and NovaBay Pharmaceuticals (NBY) by 5.51%.
January 29, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adaptimmune Therapeutics' stock fell 6.77% to $0.74, with a market cap of $168.1 million.
The decrease in after-market trading hours could indicate a negative short-term outlook for Adaptimmune Therapeutics.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Butterfly Network's shares declined by 6.53% to $1.0, with a market cap of $207.1 million.
The after-market decline may suggest a short-term bearish sentiment for Butterfly Network's stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
NovaBay Pharmaceuticals' stock decreased by 5.51% to $0.17, with a market cap of $1.1 million.
The after-market drop could be a sign of short-term negative sentiment towards NovaBay Pharmaceuticals.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
OneMedNet's shares decreased by 12.6% in after-market trading, with a market cap of $38.0 million.
A significant after-market decrease is typically a negative indicator and could suggest a short-term downward trend in the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Palisade Bio's shares declined by 10.95% to $0.85, with a market cap of $7.9 million.
The after-market decline could negatively affect Palisade Bio's stock price in the short term, reflecting investor concerns.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Soleno Therapeutics' stock declined by 6.11% to $45.06, with a market cap of $1.3 billion.
The negative movement after market hours could lead to a short-term downward pressure on Soleno Therapeutics' stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Agape ATP's stock surged by 39.2% in after-market trading, with a market cap of $54.7 million.
A significant after-market increase often indicates positive investor sentiment which could lead to a short-term continuation of the upward trend.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
CNS Pharma's stock rose 14.52% in after-market trading, with a market cap of $2.3 million.
The after-market rise could lead to a short-term positive impact on the stock price, reflecting increased investor confidence.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Ekso Bionics Holdings' stock increased by 10.22% in after-market trading, with a market cap of $34.5 million.
The stock's after-market gain suggests a positive short-term outlook, potentially due to favorable investor perception.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
NanoVibronix's stock rose 8.21% in after-market trading, with a market cap of $2.1 million.
The positive movement in after-market hours could suggest a short-term upward trend for NanoVibronix's stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Oncternal Therapeutics' shares increased by 9.56% to $10.93, with a market cap of $32.3 million.
The increase in after-market trading may indicate short-term bullish sentiment among investors for Oncternal Therapeutics.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Alaunos Therapeutics' stock moved upwards by 7.79% to $0.17, with a market cap of $40.9 million.
The after-market increase may lead to a short-term positive impact on TCRT's stock price, indicating investor interest.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80